Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Dec;58(6):793–796. doi: 10.1038/bjc.1988.311

Bone disease in testicular and extragonadal germ cell tumours.

R N Hitchins 1, P A Philip 1, B Wignall 1, E S Newlands 1, R H Begent 1, G J Rustin 1, K D Bagshawe 1
PMCID: PMC2246879  PMID: 3224081

Abstract

Of 297 patients with metastatic testicular and extragonadal germ cell tumours (GCT), bone involvement was detected clinically in 3% (7/251) of those at first presentation and in 9% (4/46) of relapsed cases. This difference was not statistically significant (95% confidence limits -2%; +14%). Concurrent systemic metastases, commonly involving lung (7/11 cases) and para-aortic lymph nodes (6/11), were present in all patients with bone disease. All affected patients had localized bone pain and lumbar spine was the most frequent site involved (9/11). Spinal cord compression occurred in two patients while a third developed progressive vertebral collapse after chemotherapy and required extensive surgical reconstruction. At median follow-up of 4 years, survival among patients presenting with bone disease (6/7) was similar to overall survival in the whole group (84%) and appeared better than in those with liver (18/26, 69%) or central nervous system (6/9) metastases at presentation. Back pain in metastatic germ cell tumours is often due to retroperitoneal lymphadenopathy but lumbar spine osseus metastases must be recognized early if severe potential complications, such as spinal cord compression, are to be avoided. In this series, bone metastases were not seen in the absence of widespread systemic disease suggesting all solitary bony lesions in GCT patients should be biopsied.

Full text

PDF
793

Images in this article

795Figure 1
on p.795
795Figure 2
on p.795

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bajorin D., Katz A., Chan E., Geller N., Vogelzang N., Bosl G. J. Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies. J Clin Oncol. 1988 May;6(5):786–792. doi: 10.1200/JCO.1988.6.5.786. [DOI] [PubMed] [Google Scholar]
  2. Ball D., Barrett A., Peckham M. J. The management of metastatic seminoma testis. Cancer. 1982 Dec 1;50(11):2289–2294. doi: 10.1002/1097-0142(19821201)50:11<2289::aid-cncr2820501112>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  3. Bosl G. J., Gluckman R., Geller N. L., Golbey R. B., Whitmore W. F., Jr, Herr H., Sogani P., Morse M., Martini N., Bains M. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. J Clin Oncol. 1986 Oct;4(10):1493–1499. doi: 10.1200/JCO.1986.4.10.1493. [DOI] [PubMed] [Google Scholar]
  4. Bredael J. J., Vugrin D., Whitmore W. F., Jr Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer. 1982 Aug 1;50(3):548–551. doi: 10.1002/1097-0142(19820801)50:3<548::aid-cncr2820500327>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Cantwell B. M., Mannix K. A., Harris A. L. Back pain--a presentation of metastatic testicular germ cell tumours. Lancet. 1987 Jan 31;1(8527):262–264. doi: 10.1016/s0140-6736(87)90075-4. [DOI] [PubMed] [Google Scholar]
  6. Collis C. H., Eckert H. Seminoma of the testis with bone involvement: a report of three cases. Clin Radiol. 1985 Sep;36(5):467–468. doi: 10.1016/s0009-9260(85)80188-4. [DOI] [PubMed] [Google Scholar]
  7. DIXON F. J., MOORE R. A. Testicular tumors; a clinicopathological study. Cancer. 1953 May;6(3):427–454. doi: 10.1002/1097-0142(195305)6:3<427::aid-cncr2820060302>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  8. Duncan W., Munro A. J. The management of testicular seminoma: Edinburgh 1970-1981. Br J Cancer. 1987 Apr;55(4):443–448. doi: 10.1038/bjc.1987.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gay J. C., Janco R. L., Lukens J. N. Systemic metastases in primary intracranial germinoma. Case report and literature review. Cancer. 1985 Jun 1;55(11):2688–2690. doi: 10.1002/1097-0142(19850601)55:11<2688::aid-cncr2820551125>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  10. Hay J. H., Duncan W., Kerr G. R. Radiotherapy of testicular tumours: an analysis of patients treated in Scotland between 1950 and 1969. Clin Radiol. 1984 Jan;35(1):13–16. doi: 10.1016/s0009-9260(84)80218-4. [DOI] [PubMed] [Google Scholar]
  11. Hermann G., Novick A., Carr L. Skeletal metastases of seminoma of the testicle. Mt Sinai J Med. 1986 Apr;53(4):294–296. [PubMed] [Google Scholar]
  12. Johnson D. E., Appelt G., Samuels M. L., Luna M. Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology. 1976 Sep;8(3):234–239. doi: 10.1016/0090-4295(76)90374-5. [DOI] [PubMed] [Google Scholar]
  13. Loehrer P. J., Sr, Birch R., Williams S. D., Greco F. A., Einhorn L. H. Chemotherapy of metastatic seminoma: the Southeastern Cancer Study Group experience. J Clin Oncol. 1987 Aug;5(8):1212–1220. doi: 10.1200/JCO.1987.5.8.1212. [DOI] [PubMed] [Google Scholar]
  14. Logothetis C. J., Samuels M. L., Selig D. E., Ogden S., Dexeus F., Swanson D., Johnson D., von Eschenbach A. Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients. Am J Med. 1986 Aug;81(2):219–228. doi: 10.1016/0002-9343(86)90255-x. [DOI] [PubMed] [Google Scholar]
  15. Martini N., Golbey R. B., Hajdu S. I., Whitmore W. F., Beattie E. J., Jr Primary mediastinal germ cell tumors. Cancer. 1974 Mar;33(3):763–769. doi: 10.1002/1097-0142(197403)33:3<763::aid-cncr2820330323>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  16. Mostofi F. K. Proceedings: Testicular tumors. Epidemiologic, etiologic, and pathologic features. Cancer. 1973 Nov;32(5):1186–1201. doi: 10.1002/1097-0142(197311)32:5<1186::aid-cncr2820320527>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  17. Newlands E. S., Bagshawe K. D., Begent R. H., Rustin G. J., Crawford S. M., Holden L. Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol. 1986 Jun;58(3):307–314. doi: 10.1111/j.1464-410x.1986.tb09061.x. [DOI] [PubMed] [Google Scholar]
  18. Richardson R. L., Schoumacher R. A., Fer M. F., Hande K. R., Forbes J. T., Oldham R. K., Greco F. A. The unrecognized extragonadal germ cell cancer syndrome. Ann Intern Med. 1981 Feb;94(2):181–186. doi: 10.7326/0003-4819-94-2-181. [DOI] [PubMed] [Google Scholar]
  19. Sagalowsky A. I., McConnell J. D., Admire R. Uncommon sites of recurrent seminoma and implications for therapy. Cancer. 1986 Mar 1;57(5):1060–1065. doi: 10.1002/1097-0142(19860301)57:5<1060::aid-cncr2820570533>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  20. Stanton G. F., Bosl G. J., Whitmore W. F., Jr, Herr H., Sogani P., Morse M., Golbey R. B. VAB-6 as initial treatment of patients with advanced seminoma. J Clin Oncol. 1985 Mar;3(3):336–339. doi: 10.1200/JCO.1985.3.3.336. [DOI] [PubMed] [Google Scholar]
  21. Williams S. D., Birch R., Einhorn L. H., Irwin L., Greco F. A., Loehrer P. J. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med. 1987 Jun 4;316(23):1435–1440. doi: 10.1056/NEJM198706043162302. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES